NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDEculizumab  Nutrition and blood, Drugs used in hypoplastic, haemolytic, and renal anaemias and in sickle cell disease, 09.01.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Eculizumab Eculizumab Blood And Blood-Forming Organs, Immunosuppressants, Complement Inhibitors
Anaemias, Hypoplastic, Haemolytic, And Renal Anaemias, Atypical Haemolytic Uraemic Syndrome And Paroxysmal Nocturnal Haemoglobinuria
Eculizumab Eculizumab Immune System, Immunosuppressants, Complement Inhibitors
Immune System Disorders And Transplantation
Eculizumab Eculizumab Musculoskeletal System, Immunosuppressants, Complement Inhibitors
Neuromuscular Disorders, Myasthenia Gravis And Lambert-Eaton Myasthenic Syndrome
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
Clinical Commissioning Policy; Rituximab and eculizumab for the prevention and management of delayed haemolytic transfusion reactions and hyperhaemolysis in patients with haemoglobinopathies [URN 1821] [200602P]
NICE TA1010: Danicopan with ravulizumab or eculizumab for treating paroxysmal nocturnal haemoglobinuria